The role of microRNAs in enteroviral infections

Brazilian Journal of Infectious Diseases

Volumn 19, Issue 5, 2015, Pages 510-516

  Wu, Jing ^a   Shen, Li ^b   Chen, Jianguo ^c   Xu, Huaxi ^a   Mao, Lingxiang ^a,b  

^a JIANGSU UNIVERSITY   (China)

^b Zhenjiang Center for Disease Control and Prevention   (China)

^c AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

Author keywords

Enterovirus; Infection; MicroRNAs

Indexed keywords

MICRORNA; MICRORNA 140 5P; MICRORNA 143; MICRORNA 146A; MICRORNA 148A; MICRORNA 155; MICRORNA 21; MICRORNA 23A; MICRORNA 29A; MICRORNA 324 3P; MICRORNA 342 5P; MICRORNA 362 3P; MICRORNA 374; MICRORNA 542 5P; MICRORNA 545; MICRORNA 548; MICRORNA 628 3P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; COXSACKIEVIRUS B3; DISEASE ASSOCIATION; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; GENE EXPRESSION REGULATION; GENE SEQUENCE; HOST PATHOGEN INTERACTION; HUMAN; INNATE IMMUNITY; NONHUMAN; PROTEIN TARGETING; RNA ANALYSIS; RNA BINDING; SHORT SURVEY; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; GENE EXPRESSION PROFILING; GENETICS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; PICORNAVIRIDAE;

ENTEROVIRUS INFECTIONS; GENE EXPRESSION PROFILING; HUMANS; MICRORNAS; PICORNAVIRIDAE; VIRUS REPLICATION;

EID: 84942550165     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/j.bjid.2015.06.011     Document Type: Short Survey

References (68)

1. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
2. Lahmy R., Soleimani M., Sanati M.H., Behmanesh M., Kouhkan F., Mobarra N. MiRNA-375 promotes beta pancreatic differentiation in human induced pluripotent stem (hiPS) cells. Mol Biol Rep 2014, 41:2055-2066.
3. Corthals S.L., Jongen-Lavrencic M., de Knegt Y., et al. Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma. Leuk Res 2010, 34:677-681.
4. Wu L., Fan J., Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci U S A 2006, 103:4034-4039.
5. Mourelatos Z., Dostie J., Paushkin S., et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 2002, 16:720-728.
6. Meister G., Tuschl T. Mechanisms of gene silencing by double-stranded RNA. Nature 2004, 431:343-349.
7. Brown B.D., Gentner B., Cantore A., et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol 2007, 25:1457-1467.
8. Westerhout E.M., Ooms M., Vink M., Das A.T., Berkhout B. HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005, 33:796-804.
9. Gu S., Jin L., Zhang F., Sarnow P., Kay M.A. Biological basis for restriction of microRNA targets to the 3' untranslated region in mammalian mRNAs. Nat Struct Mol Biol 2009, 16:144-150.
10. Doench J.G., Sharp P.A. Specificity of microRNA target selection in translational repression. Genes Dev 2004, 18:504-511.
11. Roberts A.P., Lewis A.P., Jopling C.L. miR-122 activates hepatitis C virus translation by a specialized mechanism requiring particular RNA components. Nucleic Acids Res 2011, 39:7716-7729.
12. Tay Y., Zhang J., Thomson A.M., et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008, 455:1124-1128.
13. Hobert O. Gene regulation by transcription factors and microRNAs. Science 2008, 319:1785-1786.
14. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
15. Cullen B.R. Viral and cellular messenger RNA targets of viral microRNAs. Nature 2009, 457:421-425.
16. Shukla G.C., Singh J., Barik S. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol Cell Pharmacol 2011, 3:83-92.
17. Oberste M.S., Maher K., Kilpatrick D.R., Pallansch M.A. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol 1999, 73:1941-1948.
18. Li L., He Y., Yang H., et al. Genetic characteristics of human enterovirus 71 and coxsackievirus A16 circulating from 1999 to 2004 in Shenzhen, People's Republic of China. J Clin Microbiol 2005, 43:3835-3839.
19. Wang Y.F., Chou C.T., Lei H.Y., et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J Virol 2004, 78:7916-7924.
20. Wong K.T., Munisamy B., Ong K.C., et al. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J Neuropathol Exp Neurol 2008, 67:162-169.
21. Knowlton K.U. CVB infection and mechanisms of viral cardiomyopathy. Curr Top Microbiol Immunol 2008, 323:315-335.
22. Yajima T., Knowlton K.U. Viral myocarditis: from the perspective of the virus. Circulation 2009, 119:2615-2624.
23. Sarmiento L., Frisk G., Anagandula M., Cabrera-Rode E., Roivainen M., Cilio C.M. Expression of innate immunity genes and damage of primary human pancreatic islets by epidemic strains of echovirus: implication for post-virus islet autoimmunity. PLoS ONE 2013, 8:e77850.
24. Takamatsu Y., Uchida L., Nga P.T., et al. An approach for differentiating echovirus 30 and Japanese encephalitis virus infections in acute meningitis/encephalitis: a retrospective study of 103 cases in Vietnam. Virol J 2013, 10:280. DCOM-20140623.
25. Yarmolskaya M.S., Shumilina E.Y., Ivanova O.E., Drexler J.F., Lukashev A.N. Molecular epidemiology of echoviruses 11 and 30 in Russia: different properties of genotypes within an enterovirus serotype. Infect Genet Evol 2015, 30:244-248.
26. Persu A., Baicus A., Stavri S., Stavri S., Combiescu M., Combiescu M. Non-polio enteroviruses associated with acute flaccid paralysis (AFP) and facial paralysis (FP) cases in Romania, 2001-2008. Roum Arch Microbiol Immunol 2009, 68:20-26. DCOM-20090708.
27. Fu Y., Wei X., Tang C., et al. Circulating microRNA-101 as a potential biomarker for hepatitis B virus-related hepatocellular carcinoma. Oncol Lett 2013, 6:1811-1815.
28. Zhang T., Zhang J., Cui M., et al. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Neoplasia 2013, 15:1282-1291.
29. Ahluwalia J.K., Khan S.Z., Soni K., et al. Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 2008, 5:117.
30. Sung T.L., Rice A.P. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 2009, 5:e1000263.
31. Jopling C.L., Schutz S., Sarnow P. Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 2008, 4:77-85.
32. Niepmann M. Activation of hepatitis C virus translation by a liver-specific microRNA. Cell Cycle 2009, 8:1473-1477.
33. Shimakami T., Yamane D., Welsch C., Hensley L., Jangra R.K., Lemon S.M. Base pairing between hepatitis C virus RNA and microRNA 122 3' of its seed sequence is essential for genome stabilization and production of infectious virus. J Virol 2012, 86:7372-7383.
34. Lui Y.L., Tan T.L., Woo W.H., et al. Enterovirus71 (EV71) utilise host microRNAs to mediate host immune system enhancing survival during infection. PLoS ONE 2014, 9:e102997.
35. Cui L., Guo X., Qi Y., et al. Identification of microRNAs involved in the host response to enterovirus 71 infection by a deep sequencing approach. J Biomed Biotechnol 2010, 2010:425939.
36. Cui L., Qi Y., Li H., et al. Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS ONE 2011, 6:e27071. DCOM-20120518.
37. Zheng Z., Ke X., Wang M., et al. Human microRNA hsa-miR-296-5p suppresses enterovirus 71 replication by targeting the viral genome. J Virol 2013, 87:5645-5656.
38. Wen B.P., Dai H.J., Yang Y.H., Zhuang Y., Sheng R. MicroRNA-23b inhibits enterovirus 71 replication through downregulation of EV71 VPl protein. Intervirology 2013, 56:195-200.
39. Yang Z., Tien P. MiR373 and miR542-5p regulate the replication of enterovirus 71 in rhabdomyosarcoma cells. Sheng Wu Gong Cheng Xue Bao 2014, 30:943-953.
40. Mihm S. Activation of type I and type III interferons in chronic hepatitis C. J Innate Immun 2015, 7:251-259.
41. Li Y., Xie J., Xu X., et al. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-lambda1. Protein Cell 2013, 4:130-141.
42. Ho B.C., Yu I.S., Lu L.F., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat Commun 2014, 5:3344.
43. Xu C., He X., Zheng Z., et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent innate immune response. J Virol 2014, 88:11356-11368. 10.1128/JVI.01400-01414.
44. Chang Y.L., Ho B.C., Sher S., Yu S.L., Yang P.C. miR-146a and miR-370 coordinate enterovirus 71-induced cell apoptosis through targeting SOS1 and GADD45beta. Cell Microbiol 2014, 3.
45. Ho B.C., Yu S.L., Chen J.J., et al. Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E. Cell Host Microbe 2011, 9:58-69.
46. Zhang L., Chen X., Shi Y., et al. miR-27a suppresses EV71 replication by directly targeting EGFR. Virus Genes 2014, 49:373-382.
47. Xu L.J., Jiang T., Zhao W., et al. Parallel mRNA and microRNA profiling of HEV71-infected human neuroblastoma cells reveal the up-regulation of miR-1246 in association with DLG3 repression. PLoS ONE 2014, 9:e95272.
48. Zhang Q., Xiao Z., He F., Zou J., Wu S., Liu Z. MicroRNAs regulate the pathogenesis of CVB3-induced viral myocarditis. Intervirology 2013, 56:104-113.
49. Wang L., Qin Y., Tong L., et al. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region. Antiviral Res 2012, 93:270-279.
50. Tong L., Lin L., Wu S., et al. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence. Nucleic Acids Res 2013, 41:3760-3771.
51. Hemida M.G., Ye X., Zhang H.M., et al. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148. Cell Mol Life Sci 2013, 70:277-291.
52. Rodriguez A., Vigorito E., Clare S., et al. Requirement of bic/microRNA-155 for normal immune function. Science 2007, 316:608-611.
53. Corsten M.F., Papageorgiou A., Verhesen W., et al. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis. Circ Res 2012, 111:415-425.
54. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci USA 2007, 104:1604-1609.
55. Ye X., Hemida M.G., Qiu Y., Hanson P.J., Zhang H.M., Yang D. MiR-126 promotes coxsackievirus replication by mediating cross-talk of ERK1/2 and Wnt/beta-catenin signal pathways. Cell Mol Life Sci 2013, 70:4631-4644.
56. Xu H.F., Ding Y.J., Shen Y.-W., et al. MicroRNA-1 represses Cx43 expression in viral myocarditis. Mol Cell Biochem 2012, 362:141-148.
57. He J., Yue Y., Dong C., Xiong S. MiR-21 confers resistance against CVB3-induced myocarditis by inhibiting PDCD4-mediated apoptosis. Clin Invest Med 2013, 36:E103-E111.
58. Liu Y.L., Wu W., Xue Y., et al. MicroRNA-21 and -146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch Virol 2013, 158:1953-1963.
59. Ye X., Zhang H.M., Qiu Y., et al. Coxsackievirus-induced miR-21 disrupts cardiomyocyte interactions via the downregulation of intercalated disk components. PLoS Pathog 2014, 10:e1004070. DCOM-20141210.
60. Xu H.F., Ding Y.J., Zhang Z.X., et al. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep 2014, 10:161-168. DCOM-20150113.
61. Choi B., Kim H.A., Suh C.H., Byun H.O., Jung J.Y., Sohn S. The relevance of miRNA-21 in HSV-induced inflammation in a mouse model. Int J Mol Sci 2015, 16:7413-7427.
62. Damania P., Sen B., Dar S.B., et al. Hepatitis B virus induces cell proliferation via HBx-induced microRNA-21 in hepatocellular carcinoma by targeting programmed cell death protein4 (PDCD4) and phosphatase and tensin homologue (PTEN). PLoS ONE 2014, 9:e91745.
63. Bondanese V.P., Francisco-Garcia A., Bedke N., Davies D.E., Sanchez-Elsner T. Identification of host miRNAs that may limit human rhinovirus replication. World J Biol Chem 2014, 5:437-456.
64. Ouda R., Onomoto K., Takahasi K., et al. Retinoic acid-inducible gene I-inducible miR-23b inhibits infections by minor group rhinoviruses through down-regulation of the very low density lipoprotein receptor. J Biol Chem 2011, 286:26210-26219.
65. Sayed A.S., Xia K., Salma U., Yang T., Peng J. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ 2014, 16.
66. Li X., Liu Y., Granberg K.J., et al. Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma. Oncogene 2014, 21.
67. Qi Y., Zhu Z., Shi Z., et al. Dysregulated microRNA expression in serum of non-vaccinated children with varicella. Viruses 2014, 6:1823-1836.
68. Baek J., Kang S., Min H. MicroRNA-targeting therapeutics for hepatitis C. Arch Pharm Res 2014, 37:299-305.